Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Coleman

Showing results (31-40 of 104) with videos related to

Pageof 11
Sort By:
Scientific Reports|August 16, 2022
Natural variants of human SARM1 cause both intrinsic and dominant loss-of-function influencing axon survivalMirlinda Ademi, Xiuna Yang, Michael P Coleman, et al.
The European Journal of Neuroscience|November 1, 2006
The slow Wallerian degeneration gene in vivo protects motor axons but not their cell bodies after avulsion and neonatal axotomyRobert Adalbert, Antal Nógrádi, András Szabó, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 16, 2013
Rescue of peripheral and CNS axon defects in mice lacking NMNAT2Jonathan Gilley, Robert Adalbert, Gang Yu, et al.
Neuroreport|October 19, 2018
P7C3-A20 neuroprotection is independent of Wallerian degeneration in primary neuronal cultureCiaran S Hill, David K Menon, Michael P Coleman
Plos One|October 15, 2013
MEK inhibitor U0126 reverses protection of axons from Wallerian degeneration independently of MEK-ERK signalingCatherine Evans, Simon J Cook, Michael P Coleman, et al.
Frontiers in Molecular Biosciences|July 26, 2021
A Novel NAD Signaling Mechanism in Axon Degeneration and its Relationship to Innate ImmunityEleanor L Hopkins, Weixi Gu, Bostjan Kobe, et al.
Neurobiology of Aging|December 3, 2014
Axonal transport declines with age in two distinct phases separated by a period of relative stabilityStefan Milde, Robert Adalbert, M Handan Elaman, et al.
Cell Reports|March 31, 2015
Absence of SARM1 rescues development and survival of NMNAT2-deficient axonsJonathan Gilley, Giuseppe Orsomando, Isabel Nascimento-Ferreira, et al.
Human Molecular Genetics|October 11, 2018
Low levels of NMNAT2 compromise axon development and survivalJonathan Gilley, Paul R Mayer, Gang Yu, et al.
The European Journal of Neuroscience|September 12, 2008
The WldS gene delays axonal but not somatic degeneration in a rat glaucoma modelBogdan Beirowski, Elisabetta Babetto, Michael P Coleman, et al.
Pageof 11

Showing results (31-40 of 104) with videos related to

Sort By:
Pageof 11
Scientific Reports|August 16, 2022
Natural variants of human SARM1 cause both intrinsic and dominant loss-of-function influencing axon survivalMirlinda Ademi, Xiuna Yang, Michael P Coleman, et al.
The European Journal of Neuroscience|November 1, 2006
The slow Wallerian degeneration gene in vivo protects motor axons but not their cell bodies after avulsion and neonatal axotomyRobert Adalbert, Antal Nógrádi, András Szabó, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 16, 2013
Rescue of peripheral and CNS axon defects in mice lacking NMNAT2Jonathan Gilley, Robert Adalbert, Gang Yu, et al.
Neuroreport|October 19, 2018
P7C3-A20 neuroprotection is independent of Wallerian degeneration in primary neuronal cultureCiaran S Hill, David K Menon, Michael P Coleman
Plos One|October 15, 2013
MEK inhibitor U0126 reverses protection of axons from Wallerian degeneration independently of MEK-ERK signalingCatherine Evans, Simon J Cook, Michael P Coleman, et al.
Frontiers in Molecular Biosciences|July 26, 2021
A Novel NAD Signaling Mechanism in Axon Degeneration and its Relationship to Innate ImmunityEleanor L Hopkins, Weixi Gu, Bostjan Kobe, et al.
Neurobiology of Aging|December 3, 2014
Axonal transport declines with age in two distinct phases separated by a period of relative stabilityStefan Milde, Robert Adalbert, M Handan Elaman, et al.
Cell Reports|March 31, 2015
Absence of SARM1 rescues development and survival of NMNAT2-deficient axonsJonathan Gilley, Giuseppe Orsomando, Isabel Nascimento-Ferreira, et al.
Human Molecular Genetics|October 11, 2018
Low levels of NMNAT2 compromise axon development and survivalJonathan Gilley, Paul R Mayer, Gang Yu, et al.
The European Journal of Neuroscience|September 12, 2008
The WldS gene delays axonal but not somatic degeneration in a rat glaucoma modelBogdan Beirowski, Elisabetta Babetto, Michael P Coleman, et al.
Pageof 11